Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.

Takahiko FukuchiKentaro IwataSaori KobayashiTatsuya NakamuraGoh Ohji

Published in: BMC infectious diseases (2016)

Cefmetazole may be safely given to patients with bacteremia caused by ESBL-producers as a definitive therapy, if one can select out relatively stable patients.

Keyphrases

escherichia coli
klebsiella pneumoniae
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
multidrug resistant
pseudomonas aeruginosa
prognostic factors
gram negative
peritoneal dialysis
stem cells
mesenchymal stem cells
cystic fibrosis
bone marrow
rectal cancer